Access to early-phase oncology trials: Trajectories and outcomes of more than 26,000 patients referred to a high-volume phase I unit.
This study represents the largest real-world cohort evaluating the referral-to-treatment trajectory in EPT, with patients referred to Gustave Roussy's Drug Development Department between January 1, 2007 and December 31, 2023.